Literature DB >> 11123052

Rheumatic manifestations of current pharmacopeia.

J Brenner1, B M Solitar, B D Golden.   

Abstract

Patient complaints arising as manifestations of medication side effects are commonly encountered in clinical practice. A rheumatologist must routinely consider side effects of drugs in the differential diagnosis of many symptoms. This review will remind the reader of certain well-described and some newly reported side effects commonly encountered in an internal medicine practice. Focal points incude arthralgias/arthritis, myopathy/myositis, ANA/drug-induced lupus, bone loss/osteoporosis, and tendon rupture.

Entities:  

Mesh：

Year:  2000        PMID： 11123052     DOI： 10.1007/s11926-000-0055-1

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.592


  33 in total

1.  Isotretinoin causing acute aseptic arthropathy.

Authors:  A P Bewley; E C Rankin; N J Levell; T W Robinson
Journal:  Clin Exp Dermatol       Date:  1995-05       Impact factor: 3.470

2.  Coadministration of itraconazole with hypolipidemic agents may induce rhabdomyolysis in healthy individuals.

Authors:  M Horn
Journal:  Arch Dermatol       Date:  1996-10

3.  Mitochondrial myopathy developing on treatment with the HMG CoA reductase inhibitors--simvastatin and pravastatin.

Authors:  J D England; J C Walsh; P Stewart; I Boyd; A Rohan; G M Halmagyi
Journal:  Aust N Z J Med       Date:  1995-08

4.  Intermittent polyarthritis due to propylthiouracil.

Authors:  M Tosun; M Güler; C Erem; T Uslu; E Miskioglu
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

5.  The effects of inhaled glucocorticoids on bone mass and biochemical markers of bone homeostasis: a 1-year study of beclomethasone versus budesonide.

Authors:  A Struijs; H Mulder
Journal:  Neth J Med       Date:  1997-06       Impact factor: 1.422

Review 6.  Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis, and related disorders.

Authors:  P H Plotz; M Dalakas; R L Leff; L A Love; F W Miller; M E Cronin
Journal:  Ann Intern Med       Date:  1989-07-15       Impact factor: 25.391

7.  Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group.

Authors:  K G Saag; R Emkey; T J Schnitzer; J P Brown; F Hawkins; S Goemaere; G Thamsborg; U A Liberman; P D Delmas; M P Malice; M Czachur; A G Daifotis
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

8.  Thyroid hormone use and bone mineral density in elderly women. Effects of estrogen.

Authors:  D L Schneider; E L Barrett-Connor; D J Morton
Journal:  JAMA       Date:  1994-04-27       Impact factor: 56.272

Review 9.  Antithyroid arthritis syndrome.

Authors:  S Bajaj; M J Bell; S Shumak; R Briones-Urbina
Journal:  J Rheumatol       Date:  1998-06       Impact factor: 4.666

Review 10.  Rheumatologic complications of vitamin A and retinoids.

Authors:  G Nesher; J Zuckner
Journal:  Semin Arthritis Rheum       Date:  1995-02       Impact factor: 5.532
View more
  1 in total

1.  Nonbacterial myositis.

Authors:  Nancy F Crum-Cianflone
Journal:  Curr Infect Dis Rep       Date:  2010-09       Impact factor: 3.725
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.